Research output per year
Research output per year
Search results
-
2022
Tofacitinib for treating juvenile idiopathic arthritis: A Fast Track Appraisal. Evidence Review Group Report for the National Institute for Health and Care Excellence
Rodgers, M., Sharif, S., Walton, M. J., Harden, M., Dias, S. & Claxton, L., 2022Research output: Book/Report › Commissioned report
-
2021
Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Hodgson, R., Sharif, S., Beresford, L., Anwer, S., Walton, M. J., Wittmann, M., Harden, M., Khouja, C. L. & Dias, S., 3 Mar 2021, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
2019
Certolizumab pegol for treating moderate to severe plaque psoriasis
Walton, M. J., Sharif, S., Claxton, L., Wade, R., Hodgson, R., Harden, M. & Eastwood, A. J., 17 Apr 2019, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
2018
Tisagenlecleucel-T for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years
Walton, M. J., Sharif, S., Claxton, L., Wright, K., Hodgson, R. & Simmonds, M. C., 21 Dec 2018, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
2017
Etirinotecan pegol for treating breast cancer with brain metastases
Claxton, L., Wade, R., Sharif, S., Harden, M., Woolacott, N. F. & Hodgson, R., 11 Jul 2017, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report